Partnership to Offer NIPT Test for Fast Screening

Premaitha Health, developers of the IONA® test for non-invasive prenatal screening (NIPT), has signed an agreement with This Is My Limited, a private ultrasound and pregnancy screening clinic group, to provide its test to pregnant women in Leeds, Manchester, Liverpool, Hull, Coventry, Halifax, Durham and London.

The test can estimate the risk of a foetus being affected by Down’s syndrome and other serious genetic conditions such as Patau’s syndrome or Edwards’ syndrome by analysing foetal DNA from a sample of maternal blood. The test can be analysed at a laboratory in the UK giving results in as little as five days.

Dr Stephen Little, CEO of Premaitha said: “NIPT is a substantial improvement to the current standard of pregnancy care. This Is My share our mission to make the IONA® test available to as many pregnant women as possible in the UK and have selected the IONA® test as the preferred NIPT that they offer.”

Judith Pilling, MD of This Is My said: “This agreement establishes This is My as one of the first private companies in the UK to offer Premaitha’s ground-breaking IONA® test. We are very pleased to partner with another UK company to deliver what we consider to be the gold-standard in non-invasive prenatal screening to our clients. We look forward to enhancing our pregnancy service with the test, ensuring that expectant mothers can access the information they need about their pregnancy.”